Fund profile
Fund manager
Total assets
$19.27 mm
Liabilities
$33.56 k
Net assets
$19.24 mm
Number of holdings
36.00
36 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Lilly(Eli) & Co | 1.83 mm | 5.00 k shares | 9.51 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Co. | 1.69 mm | 23.50 k shares | 8.79 | Common equity | Long | USA |
ABBV Abbvie Inc | 1.62 mm | 10.00 k shares | 8.40 | Common equity | Long | USA |
MRK Merck & Co Inc | 1.55 mm | 14.00 k shares | 8.07 | Common equity | Long | USA |
PFE Pfizer Inc. | 1.54 mm | 30.00 k shares | 7.99 | Common equity | Long | USA |
NVS Novartis AG | 1.27 mm | 14.00 k shares | 6.60 | Common equity | Long | Switzerland |
JNJ Johnson & Johnson | 1.24 mm | 7.00 k shares | 6.43 | Common equity | Long | USA |
AMGN AMGEN Inc. | 1.05 mm | 4.00 k shares | 5.46 | Common equity | Long | USA |
BIIB Biogen Inc | 1.04 mm | 3.75 k shares | 5.40 | Common equity | Long | USA |
AZN Astrazeneca plc | 881.40 k | 13.00 k shares | 4.58 | Common equity | Long | UK |
GILD Gilead Sciences, Inc. | 772.65 k | 9.00 k shares | 4.02 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 712.95 k | 3.00 k shares | 3.71 | Common equity | Long | USA |
SNY Sanofi | 629.59 k | 13.00 k shares | 3.27 | Common equity | Long | France |
US BANK MMDA - USBGFS 7 | 575.27 k | 575.27 k shares | 2.99 | Short-term investment vehicle | Long | USA |
ALKS Alkermes plc | 574.86 k | 22.00 k shares | 2.99 | Common equity | Long | Ireland |
GSK GSK Plc | 412.47 k | 11.74 k shares | 2.14 | Common equity | Long | UK |
NTLA Intellia Therapeutics Inc | 348.90 k | 10.00 k shares | 1.81 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 302.16 k | 8.00 k shares | 1.57 | Common equity | Long | USA |
GE General Electric Co. | 251.37 k | 3.00 k shares | 1.31 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 243.90 k | 6.00 k shares | 1.27 | Common equity | Long | Switzerland |
OGN Organon & Co. | 234.61 k | 8.40 k shares | 1.22 | Common equity | Long | USA |
HLN Haleon plc | 117.38 k | 14.67 k shares | 0.61 | Common equity | Long | UK |
CFRXQ CONTRAFECT Corp | 98.16 k | 12.00 k shares | 0.51 | Common equity | Long | USA |
EDIT Editas Medicine Inc | 70.96 k | 8.00 k shares | 0.37 | Common equity | Long | USA |
VNDA Vanda Pharmaceuticals Inc | 51.73 k | 7.00 k shares | 0.27 | Common equity | Long | USA |
VTRS Viatris Inc | 41.43 k | 3.72 k shares | 0.22 | Common equity | Long | USA |
GALT Galectin Therapeutics Inc | 29.38 k | 26.00 k shares | 0.15 | Common equity | Long | USA |
BLUE Bluebird bio Inc | 20.76 k | 3.00 k shares | 0.11 | Common equity | Long | USA |
TSVT 2seventy bio Inc | 9.37 k | 1.00 k shares | 0.05 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 5.72 k | 44.00 k shares | 0.03 | Common equity | Long | USA |
SLRX Salarius Pharmaceuticals Inc | 3.67 k | 2.40 k shares | 0.02 | Common equity | Long | USA |
AGEN Agenus Inc | 355.20 | 148.00 shares | 0.00 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 264.00 | 44.00 k shares | 0.00 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 220.00 | 44.00 k shares | 0.00 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 132.00 | 44.00 k shares | 0.00 | Common equity | Long | USA |
IMNPQ Immune Pharmaceuticals Inc | .000000000000 | 1.00 shares | 0.00 | Common equity | Long | USA |